SCHEMBL8807137

SCHEMBL8807137

CCCNc1nc(C)c(CCN2CC3CC(c4ccc(F)cc4)C3C2)c(=O)n1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ TP53 P04637 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ CYP3A4 P08684 4/20 0.34
▸ CYP2D6 P10635 4/20 0.34
▸ TSHR P16473 4/20 0.34
▸ MAPT P10636 4/20 0.34
▸ HTR2C P28335 4/20 0.34
▸ DRD2 P14416 4/20 0.34
▸ HTR2A P28223 4/20 0.34
▸ HTR1A P08908 3/20 0.34
▸ PMP22 Q01453 3/20 0.34
▸ ADRA2A P08913 3/20 0.34
▸ ADRA2B P18089 3/20 0.34
▸ ADRA2C P18825 3/20 0.34
▸ DRD1 P21728 3/20 0.34
▸ DRD4 P21917 3/20 0.34
▸ DRD5 P21918 3/20 0.34
▸ HTR1B P28222 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8804087 0.93 TSHR (0.35) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL8804858 0.90 CYP2D6 (0.36) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL8877427 0.87 MAPT (0.40) SMN1; SMN2LMNATP53HTTCYP3A4
SCHEMBL8878777 0.86 MAPT (0.35) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL8876991 0.85 MAPT (0.37) SMN1; SMN2LMNATP53HTTCYP3A4
SCHEMBL8805524 0.84 CYP2D6 (0.35) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL8806120 0.83 CYP2D6 (0.36) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL8804868 0.82 CYP2D6 (0.35) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL9142589 0.82 CYP2D6 (0.35) SMN1; SMN2LMNATP53CYP3A4CYP2D6
SCHEMBL9139815 0.81 PTGS2 (0.34) TP53MAPTADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647231-B1 N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS, ETC. BASF AG (DE) 1997-08-27 — — EP disclosed
US-5475105-A N-substituted azabicycloheptane derivatives BASF AKTIENGESELLSCHAFT (DE) 1995-12-12 — — US disclosed
Send feedback